This course has expired. View available courses.
Infectious Disease
Eliminating Hepatitis C by 2030: what’s stigma got to do with it?
Chronic hepatitis C (HCV) treatment is still not reaching many Australians despite the introduction of curative direct-acting antiviral agents here in 2016. It is estimated that 129,640 are still living with HCV. If left untreated, at least 25% of these cases will develop cirrhosis, and many will progress to end-stage liver disease and liver cancer.
Why are these people not presenting for treatment? Stigma still represents a key barrier to diagnosis and treatment. Australia’s Fifth National Hepatitis C Strategy 2018–2022 has identified stigma and discrimination as one of five key priority areas for action. This podcast aims to empower GPs to recognise the different ways in which stigma related to HCV infection can present in the primary care setting and consider communication techniques and tools to help overcome this – thereby optimising outcomes for patients with HCV infection.
This program is supported by an independent educational grant provided from Gilead.
DURATION
30 mins
PROFESSION
Physician, Nursing
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2022-12-31
Chronic hepatitis C (HCV) treatment is still not reaching many Australians despite the introduction of curative direct-acting antiviral agents here in 2016. It is estimated that 129,640 are still living with HCV. If left untreated, at least 25% of these cases will develop cirrhosis, and many will progress to end-stage liver disease and liver cancer.
Why are these people not presenting for treatment? Stigma still represents a key barrier to diagnosis and treatment. Australia’s Fifth National Hepatitis C Strategy 2018–2022 has identified stigma and discrimination as one of five key priority areas for action. This podcast aims to empower GPs to recognise the different ways in which stigma related to HCV infection can present in the primary care setting and consider communication techniques and tools to help overcome this – thereby optimising outcomes for patients with HCV infection.
This program is supported by an independent educational grant provided from Gilead.
Faculty
Dr Annie Balcomb
Dr Nada Andric
Learning objectives
After listening to this podcast, GP's will be able to:
- Recognise the different ways in which stigma related to HCV infection can present in the primary care setting
- Describe the ways in which stigma can have a negative impact on outcomes for patients with HCV infection
- Understand the ways in which addressing stigma in primary care can help achieve the goal of eliminating HCV by 2030
- Reflect on how stigma associated with HCV infection can be proactively mitigated in everyday practice